Combined Effects of Coenzyme Q10 & L-Carnitine on Neuroinflammation in a Rat Model of Multiple Sclerosis.
Journal of Rawalpindi Medical College · 2026
DOI: 10.37939/jrmc.3243 ↗Abstract
Objective: This study aimed to determine the potential additive effects of Coenzyme Q10 and L-Carnitine on neuroinflammation in a rat model of Multiple Sclerosis (MS), based on histological and biochemical parameters. Methods: This Experimental study was conducted at Islamic International Medical College in collaboration with NIH from March 2023 to June 2023. Fifty male Sprague-Dawley rats were randomly divided into five groups of ten rats each. Group 1 served as a negative control. The remaining groups were disease models, administered 0.2% cuprizone w/w to induce MS. After 4 weeks, Group 3 received 100 mg/kg/day L-carnitine, Group 4 received 150 mg/kg/day CoQ10, and Group 5 received both, while cuprizone administration continued. The experiment lasted for 12 weeks, after which the rats were sacrificed, and their brains were dissected. Coronal sections were stained with H & E to evaluate inflammatory infiltrates. IL-6 and TNF-α levels in the neuronal tissue were measured using ELISA kits. Results: The combined treatment group showed a significant reduction in inflammatory infiltrates compared to the CPZ group (p ≤ 0.001). Better control of the reduction in IL-6 and TNF-α levels was observed in the combination group than in the single-agent group (p ≤ 0.05). Conclusion: The study concluded that CoQ10 and L-carnitine have a potential additive effect in controlling neuroinflammation, as evidenced by fewer inflammatory infiltrates and reduced levels of IL-6 and TNF-α. Keywords: Coenzyme Q10, L-Carnitine, Inflammatory Infiltrate, Neuroinflammation.
EUVIMED